Mark Alfenito

Chief Executive Officer at ENGEN BIO

Mark Alfenito's scientific training pairs with a strong transactional background which makes him an excellent liaison between the scientific and strategic spheres. More than 20 years of experience in the biotech industry has equipped him with a deep understanding of the ins and outs of idea development, fundraising for new projects and collaborations, business structure, and intellectual property, as well as clinical, manufacturing, and licensing processes as they relate to pharmaceuticals. His prior accomplishments include private and venture-backed financings, leading to two successful IPOs, as well as more than $600M of corporate deals and transactions. An active scientific thinker, Mark holds 13 issued patents.

Mark has a BS from Cornell University, an MS & Ph.D. in Cellular and Developmental Biology from Harvard University, and a postdoctoral fellowship from Stanford University.

Location

Redwood City, United States

Links


Org chart


Teams


Offices


ENGEN BIO

EnGen is an early-stage biotechnology company pioneering a new approach to preventing and treating influenza.


Industries

Employees

1-10

Links